FDFs
fpd.opr@egis.hu
APIs
bulk.opr@egis.hu
Services:
pharmaservices@egis.hu
https://hungarytoday.hu/hungarian-pharmaceutical-company-debuts-new-services-in-barcelona/
https://finchannel.com/suprastin-becomes-georgian-consumers-favorite-allergy-remedy/116293/golden-brand-annual-award-ceremony/2023/06/
https://int.egis.health/a/egis-sponsored-the-hungarian-press-photo-contest
https://business-review.eu/business/pharmaceuticals/egis-pharmaceuticals-has-relocated-its-main-offices-at-one-tower-building-227098
https://hungarytoday.hu/coronavirus-egis-favipiravir-drug-licenced-covid-19-treatment/
https://www.businesswire.com/news/home/20211213005486/en/Crescita-Signs-Exclusive-8-Cou[%E2%80%A6]ing-Agreement-with-Egis-Pharmaceuticals-for-Pliaglis%C2%AE
https://economictimes.indiatimes.com/industry/services/property-/-cstruction/egis-group-to-invest-50-million-in-india-over-the-next-five-years/articleshow/87651487.cms
https://int.egis.health/cps/press-release-genedata-has-successfully-collaborated-with-egis-pharmaceuticals-plc-to-develop-a-pre
https://www.medindia.net/health-press-release/Egis-Pharmaceuticals-PLC-Announces-Regi[%E2%80%A6]ecision-Medicine-Tool-for-Therapy-Selection-in--516488-1.htm